Healthcare Integrated Technologies Inc
For the period ended Jan 31, 2024. Filed Mar 18, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jan 31, 2024 · Filed Mar 18, 2024
SSGCStored price and day change unavailable
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Interim Consolidated Statements of Changes in Stockholders’ Deficit (Unaudited)
INTERIM CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ DEFICIT
| Additional · Total | |||||
|---|---|---|---|---|---|
| Common Stock · Paid-In · Accumulated · Stockholders’ | |||||
| Shares | Amount | Capital | Deficit | Deficit | |
| Balances at July 31, 2023 | 68,016,167 | $68,016 | $14,878,282 | $(15,612,166) | $(665,868) |
| Net loss | - | - | - | (228,500) | (228,500) |
| Issuance of shares for services | 1,000,000 | 1,000 | (1,000) | - | - |
| Stock-based compensation | 211,523 | 212 | 21,730 | - | 21,942 |
| Activity for the three months ended October 31, 2023 | 1,211,523 | 1,212 | 20,730 | (228,500) | (206,558) |
| Net loss | - | - | - | (155,163) | (155,163) |
| Issuance of shares for cash | 1,000,000 | 1,000 | 99,000 | - | 100,000 |
| Issuance of shares for services | 100,000 | 100 | (100) | - | |
| Issuance of shares for loan modification | 326,813 | 327 | (327) | - | - |
| Stock-based compensation | 70,508 | 70 | 3,823 | - | 3,893 |
| Activity for the three months ended January 31, 2024 | 1,497,321 | 1,497 | 102,396 | (155,163) | (51,270) |
| Balances at January 31, 2024 | 70,725,011 | $70,725 | $15,001,408 | $(15,995,829) | $(923,696) |
| Additional · Total | |||||
|---|---|---|---|---|---|
| Common Stock · Paid-In · Accumulated · Stockholders’ | |||||
| Shares | Amount | Capital | Deficit | Deficit | |
| Balances at July 31, 2022 | 42,304,673 | $42,305 | $11,839,645 | $(14,309,708) | $(2,427,758) |
| Net loss | - | - | - | (642,892) | (642,892) |
| Stock-based compensation | 90,728 | 90,728 | |||
| Activity for the three months ended October 31, 2022 | - | - | 90,728 | (642,892) | (552,164) |
| Net loss | - | - | - | (218,099) | (218,099) |
| Issuance of shares for services | 250,000 | 250 | 13,500 | - | 13,750 |
| Issuance of shares for conversion of debt and related accrued interest | 120,726 | 121 | 60,242 | - | 60,363 |
| Stock-based compensation | 154,662 | 154 | 98,595 | - | 98,749 |
| Activity for the three months ended January 31, 2023 | 525,388 | 525 | 172,337 | (218,099) | (45,237) |
| Balances at January 31, 2023 | 42,830,061 | $42,830 | $12,102,710 | $(15,170,699) | $(3,025,159) |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.